E-LIB Suche - Ergebnisse für: Komori, Mika

1

Impact of Migraine on Daily Life: Results of the Observatio..:

Awaki, Etsuko ; Takeshima, Takao ; Matsumori, Yasuhiko...
Neurology and Therapy. 13 (2024) 1 - p. 165-182 , 2024

Link: https://doi.org/10.1007/..

2

Long-term treatment with lasmiditan in patients with migrai..:

Komori, Mika ; Ozeki, Akichika ; Tanji, Yuka...
The Journal of Headache and Pain. 25 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Clinical Evaluation After Discontinuation of Galcanezumab i..:

Takeshima, Takao ; Doi, Hikaru ; Ooba, Satomi...
Neurology and Therapy. 13 (2024) 3 - p. 697-714 , 2024

Link: https://doi.org/10.1007/..

4

Underrecognition of migraine‐related stigmatizing attitudes..:

Igarashi, Hisaka ; Komori, Mika ; Ueda, Kaname...
Brain and Behavior. 14 (2024) 7 - p. , 2024

Link: https://doi.org/10.1002/..

5

Lasmiditan in Japanese Patients with Common Migraine Comorb..:

Kitamura, Shigekazu ; Imai, Noboru ; Tanji, Yuka..
Journal of Pain Research. 16 (2023) - p. 1725-1738 , 2023

Link: https://doi.org/10.2147/..

6

Galcanezumab Efficacy Through the Dosing Interval in Japane..:

Shibata, Mamoru ; Nihira, Atsuko ; Tanji, Yuka...
Neurology and Therapy. 12 (2023) 6 - p. 2007-2019 , 2023

Link: https://doi.org/10.1007/..

7

Long-term treatment with lasmiditan in patients with migrai..:

Ashina, Messoud ; Roos, Caroline ; Li, Lily Qian...
Cephalalgia. 43 (2023) 4 - p. 033310242311617 , 2023

Link: https://doi.org/10.1177/..

8

Outcomes and Factors Associated with Insufficient Effective..:

Hirata, Koichi ; Komori, Mika ; Ueda, Kaname...
Drugs - Real World Outcomes. 10 (2023) 3 - p. 415-428 , 2023

Link: https://doi.org/10.1007/..

9

Rapid Onset and Sustained Efficacy of Lasmiditan Among Japa..:

Matsumori, Yasuhiko ; Komori, Mika ; Tanji, Yuka..
Neurology and Therapy. 11 (2022) 4 - p. 1721-1734 , 2022

Link: https://doi.org/10.1007/..

10

Safety profile of lasmiditan in patients with migraine in a..:

Hirata, Koichi ; Matsumori, Yasuhiko ; Tanji, Yuka...
Expert Opinion on Drug Safety. 22 (2022) 1 - p. 91-101 , 2022

Link: https://doi.org/10.1080/..

11

Superiority of Serum NFL in Predicting Multiple Sclerosis S..:

Kosa, Peter ; Masvekar, Ruturaj ; Komori, Mika...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

12

The Association Between the Occurrence of Common Treatment-..:

Doty, Erin G. ; Hauck, Paula M. ; Krege, John H....
CNS Drugs. 36 (2022) 7 - p. 771-783 , 2022

Link: https://doi.org/10.1007/..

13

Lasmiditan for Patients with Migraine and Contraindications..:

Krege, John H. ; Lipton, Richard B. ; Baygani, Simin K....
Pain and Therapy. 11 (2022) 2 - p. 701-712 , 2022

Link: https://doi.org/10.1007/..

14

Lasmiditan for single migraine attack in Japanese patients ..:

Hashimoto, Yoichiro ; Komori, Mika ; Tanji, Yuka..
Expert Opinion on Drug Safety. 21 (2022) 12 - p. 1495-1503 , 2022

Link: https://doi.org/10.1080/..

15

Efficacy of lasmiditan for the acute treatment of perimenst..:

MacGregor, E Anne ; Komori, Mika ; Krege, John Henry...
Cephalalgia. 42 (2022) 14 - p. 1467-1475 , 2022

Link: https://doi.org/10.1177/..